白云山:子公司明兴药业新增抗肿瘤药生产线

公司公告
09 Apr

白云山公告,其全资子公司广州白云山明兴制药有限公司收到广东省药品监督管理局核准签发的《药品生产许可证》,新增冻干粉针剂(抗肿瘤药)生产范围和生产线,并通过药品生产质量管理规范符合性检查。新增内容位于广州市白云区健旭三路99号生产车间“制造八部”,有效期至2025年11月22日。此变更有利于优化产能并提升智能化、数字化及绿色化水平,但对当期业绩无重大影响。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10